Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $656.1750 (-2.16%) ($656.1750 - $656.1750) on Wed. Dec. 15, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.86% (three month average) | RSI | 53 | Latest Price | $656.1750(-2.16%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.1% a day on average for past five trading days. | Weekly Trend | REGN advances 1.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(53%) DIA(39%) XLV(39%) IWD(38%) SPY(37%) | Factors Impacting REGN price | REGN will decline at least -0.93% in a week (0% probabilities). VIXM(-19%) TBT(-10%) UUP(-8%) VXX(-4%) IGOV(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.93% (StdDev 1.86%) | Hourly BBV | -0.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $665.15(-1.35%) | 10 Day Moving Average | $651.23(0.76%) | 20 Day Moving Average | $648.16(1.24%) | To recent high | -2.2% | To recent low | 20.9% | Market Cap | $69.573b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |